A novel model improves risk prediction for hypertrophic cardiomyopathy (HCM), according to results of a study.
Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous labeling and clinician uncertainty. Pathobiologic overlap with HFrEF supports ...
Two in five patients with heart failure (HF) have high inflammatory risk, with a similar prevalence across the spectrum of ...
The prediction markets shown on this page were independently selected by CNBC editors. CNBC has a commercial relationship with Kalshi and may receive a user acquisition fee if you establish a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results